Anton Jenkins

Clinigen Ltd. engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom.

Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom.

AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.

Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom.

Part of Teva Pharmaceutical Industries Ltd., IVAX Pharmaceuticals (UK) Ltd. is a British company that manufactures and distributes pharmaceutical products. The company is based in London, UK.

May & Baker Ltd. manufactures pharmaceutical products. The company is headquartered in Guildford, GB.

Part of GEA Group AG, ICG (UK) Ltd. is a manufacturer of evaporators and condensers for the industrial refrigeration markets. The company is based in Fareham, UK. ICG (UK was acquired by GEA Group AG on August 27, 2008.

Part of Amber Therapeutics Ltd., Bioinduction Ltd. is a British company that manufactures closed-loop neuromodulation therapies. The company is based in Bristol, UK. The company was founded in 2002 by Ivor Stephen Gillbe, Nikunj Kantilal Patel. Bioinduction was acquired by Amber Therapeutics Ltd. on September 05, 2023.